after yesterday's positive announcement, page-25

re: "still doesn't spell out whether it actually is more effective at reducing parasite numbers which is the critical point-"

Just a minor point. I don't think that ArTimist has to be more effective than intravenous quinine, as I may have read in your post.
My guess is that the intravenous quinine is the 'standard control' for this trial and others.
I think this trial is testing this delivery system results against the historical results of other delivery system trials, ie: tablets vs intravenous quinine. If so, they must have a mountain of data to wade through and process into a valid report.
I think they have good results, hence a surge in the share price a month or so ago. If they didn't have good results it would have shown up immediately in the blood tests, and would have been compelled to post a failure. So if their results are good, they just have to produce a quality, well reviewed report that validates their claims.
Only a couple of months wait for a report such as this says to me that they are really moving on this.

"The new delivery system overcomes all the current problems of anti malaria tablets and has distinct advantages over other complicated malaria treatments."

"ArTiMistTMs benefits over other malaria treatments include:
No adverse effects: Phase 1 single and Multi dose clinical trials showed that it was well tolerated and showed no adverse effects in any of the trial subjects.
Easy to administer: There is no drug to swallow, no need for an injection and no requirement for a suppository. The drug is a single multi dose unit (spray canister) which would only require simple instructions and training for administration. It can therefore be used in the remote areas without clinical intervention.
Improved bio-availability: The more effective delivery method is backed up by an independent report stating a 70% improvement in the availability of the active ingredient in
the blood over a tablet alternative."

http://www.eastlandmedical.com/Uploads/Images/EMS%20Pat%20Report.pdf